Emergen Research latest document, titled ‘Global wearable injectors Market - Forecast to 2027,’ is one of the most sought-after market reports involving an in-depth analysis of the global wearable injectors market. The report’s authors have offered necessary details on the latest wearable injectors market trends and the crucial parameters impacting both short-term and long-term market growth. Its panoramic view of the wearable injectors industry entails useful insights into the estimated wearable injectors market size, revenue share, and sales distribution network such helpful market insights are bound to help readers outline this industry’s key outcomes in the near future.
Our experienced market research team has provided updated information on the ongoing COVID-19 pandemic and its adverse economic impact in the latter segment of the report. The coronavirus outbreak has led to drastic changes in the current wearable injectors business landscape, limiting the growth opportunities for various manufacturers and buyers for the next few years. Besides making speculations about the market’s post-COVID-19 scenario, the report discusses its existing situation. The report eventually offers conclusive data related to the wearable injectors market growth assessed on both regional and global levels.
Get a Free sample of the report : https://www.emergenresearch.com/request-sample/543
The ability to track and manage therapy and avoid over-dose, double injections, or missed injections are propelling adoption of wearable injectors. These devices also help in improving patient adherence and therapy outcomes. Moreover, lightweight feature, feature of prefilled glass cartridge, and high tolerant adhesive nature of wearable injectors are other factors boosting growth of the market.
Some Key Highlights in the Report
In August 2019, Genentech of Roche entered into collaboration with Enable Injections, which is a developer and designer of wearable investigation testing, for ‘Combination Goods’ infusion devices. The partnership was created for multiple programs based on the en-Fuse platform of Enable.
The spring-based segment accounted for largest revenue share in 2020 due to rising preference, driven by more ease of use as compared to conventional procedures.
The on-body wearable injectors segment revenue is expected to expand at a rapid CAGR during the forecast period. Demand for on-body wearable injectors is relatively high currently, and this segment is expected to account for a significantly robust revenue growth during the forecast period. On-body wearable injectors enable patients to self-administer treatments at home, which is more comfortable and cost-effective.
The immune-oncology segment accounted for largest revenue share among other application segments in the wearable injectors market in 2020, driven by increasing prevalence of cancer among the growing geriatric population and rising adoption of wearable injectors that are easy to use, more cost-effective, and less painful.
The home care setting segment accounted for the largest revenue share than other end-use segments in 2020 due to increasing research and development initiatives for production of more advanced and cost-effective self-injection systems for use in home care settings.
North America accounted for largest revenue share in the global wearable injectors market in 2020. Robust presence of major players such as Amgen, Insulet Corporation, Becton, Dickinson And Company, Enable Injections, and United Therapeutics Corporation is projected to continue to boost growth of the North America wearable injectors going ahead.
Key players in the market include Medtronic, Amgen, Ypsomed, Insulet Corporation, West Pharmaceutical Services, Becton, Dickinson And Company, Enable Injections, United Therapeutics Corporation, F. Hoffmann-La Roche AG, and Johnson Johnson.
Request customization of the report: https://www.emergenresearch.com/request-for-customization/543
Emergen Research has segmented the global wearable injectors market on the basis of technology, type, application, end-use, and region:
Technology Outlook (Revenue, USD Billion; 2021–2028)
- Motor-driven
- Expanding Battery
- Spring-based
- Rotary Pump
- Others
Type Outlook (Revenue, USD Billion; 2021–2028)
- Off-body
- On-body
Application Outlook (Revenue, USD Billion; 2021–2028)
- Cardiovascular Disease
- Diabetes
- Immuno-Oncology
- Infectious Diseases
- Others
End-use Outlook (Revenue, USD Billion; 2021–2028)
- Clinics
- Hospitals
- Home Care Settings
- Others
The report objectives are:
To evaluate wearable injectors status, future forecast, growth opportunity, key market, and key players.
To present the Global wearable injectors development in the different regions of the world.
To strategically study and segment the key players and comprehensively analyze their development plan and strategies.
To define, describe, and forecast the market by product type, market, and key regions.
Overview of the wearable injectors Market Report:
Introduction, Product Scope, Market Overview, and Opportunities
Analysis of the Manufacturers with sales, revenue, and price analysis
Comprehensive analysis of the competitive landscape
Extensive profiling of the key competitors along with their business strategies and market size
Regional analysis of the market along with sales, revenue, market share, and global position
Country-wise analysis of the market along with types, applications, and manufacturing
Strategic recommendations to established players as well as new entrants
In-depth analysis of the risks, restraints, and limitations in the wearable injectors industry
Read More: https://www.emergenresearch.com/industry-report/wearable-injectors-market
Related reports:
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs